Navigation Links
Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
Date:2/2/2009

on's or Lou Gehrig's (ALS) diseases from "normal" individuals and patients with other neurological disorders. In so doing, the test helps the physician make appropriate follow-up and treatment recommendations for their patients.

Power3 Medical is currently conducting prospective clinical validation studies of NuroPro in Alzheimer's and Parkinson's diseases, with results indicating sensitivities and specificities of 85-95% for both disorders.

"Power3 Medical stands alone in the development of a highly definitive molecular test for neurodegenerative diseases, including Alzheimer's and Parkinson's," said Transgenomic CEO Craig Tuttle. "Power3 Medical's proteomics platform discriminates between disease and controls, among different types of neurological diseases, with neurodegenerative disease fitting within Transgenomic's focus on disorders originating from mitochondrial damage. NuroPro will add significant depth to complement our array of genetic tests in neurology."

Power3 Medical CEO Helen R. Park said, "This new licensing agreement provides Transgenomic with the support to offer the NuroPro test for Alzheimer's and Parkinson's diseases, addressing critical unmet needs in two large markets. It is a great relationship for both companies, combining Power3 Medical's proteomics platform technology with Transgenomic's molecular diagnostics technology, laboratory and services, and we believe will be the springboard needed for full commercialization."

Dr. Ira L. Goldknopf, Power3 Medical's President and Chief Scientific Officer, said, "The ability to accurately diagnose Alzheimer's and Parkinson's diseases early and rapidly addresses a major problem for clinicians and their patients. We believe that NuroPro may allow physicians to intervene faster and earlier with treatments to slow disease progression, before patients suffer debilitation and irreversible damage."

About T
'/>"/>

SOURCE Transgenomic, Inc.; Power3 Medical Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
2. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
3. Foreign Medical Devices are in High Demand in Russia
4. Oridion Announces Significant Medical Studies Presented at STA
5. AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi
6. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
7. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
8. ProUroCare Medical Inc. Announces Pricing of Equity Offering
9. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
10. Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients
11. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... 2015  The investigational S- equol nutritional supplement ... symptoms, such as hot flashes, according to a new ... Health .[i] "Current data suggest that women ... vasomotor symptoms and possibly additional benefits, such as skin ... equol, physicians and health care professionals may consider the ...
(Date:3/30/2015)... WHITE PLAINS, N.Y. , March 30, 2015 /PRNewswire-USNewswire/ ... developing new treatments for patients with a rare and ... from a recent licensing agreement with a new biotechnology ... has been funding this work, led by Assistant Professor ... Tomasz Cierpicki , Ph.D., at the University of Michigan, ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3
... -- ImClone,Systems Incorporated and Bristol-Myers Squibb Company ... ERBITUX(R) (Cetuximab) plus,gemcitabine (a chemotherapy) in patients ... did not meet its,primary endpoint of improving ... Oncology Group (SWOG), a cancer,center network sponsored ...
... ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ --,Telik, ... its,multicenter Phase 2 trial of the triplet ... paclitaxel will be,presented at the 98th annual ... (AACR) in Los Angeles. Preclinical studies of,cellular ...
Cached Medicine Technology:Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3
(Date:3/31/2015)... Lake, Wis. (PRWEB) March 31, 2015 ... their patients and a faster return on their investment, ... body composition analyzer at Obesity Medicine 2015, April 8-12 ... for busy weight loss centers and medical offices, Rice ... as a health assessment tool. Obesity Medicine 2015 delivers ...
(Date:3/31/2015)... Como, Italy (PRWEB) March 31, 2015 A' ... design project Food Feeder Plus by Justin Cheung has been ... in Baby, Kids' and Children's Products Design Competition ... project leader of the awarded Baby Products project Food Feeder ... to eat alone, but also means more independence for the ...
(Date:3/31/2015)... San Francisco, CA (PRWEB) March 31, 2015 ... provider of Population Health and Analytics solutions, announces the ... Sales. Bedenbaugh will work with the Senior Vice President ... transform healthcare by empowering primary care providers to create ... in the Northeast including New York, New Jersey, Connecticut, ...
(Date:3/31/2015)... March 31, 2015 A' Design Award ... project Bruker EVOQ by Daniel Dion has been announced ... in Scientific Instruments, Medical Devices and Research Equipment ... Dion, the creative mind behind the award winning Medical ... - developed under the direction of Dr. Rohan Thakur ...
(Date:3/31/2015)... Austin, TX (PRWEB) March 31, 2015 Mega ... fun photo app in the market today. This free app ... transforming them into artistically creative, exciting, and fun masterpieces. Mega ... with including twisting, morphing, pinching, warping, and spinning images in ... the game changers for Mega Photo is that it has ...
Breaking Medicine News(10 mins):Health News:Rice Lake Weighing Systems’ Body Composition Analyzer On Display at Obesity Medicine 2015 2Health News:Justin Cheung wins Golden in A' International Baby Products Design Awards 2Health News:i2i Systems Announces the Hire of Robert Bedenbaugh 2Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:New Mega Photo App Launched and Provides the Ultimate Playground for Photos 2
... 7 Natural Alternatives International, Inc. ("NAI") (Nasdaq: ... and marketer of customized nutritional supplements, today announced ... Randell Weaver,s employment with NAI ended.NAI also announced ... with Wells Fargo Bank. Among other changes ...
... Legislation Aimed at Protecting Medicare Beneficiaries Introduced on ... 7 Physical therapy ... limited by arbitrary financial caps under legislation introduced ... according to the American Physical Therapy Association (APTA). ...
... Acute lymphoblastic leukemia is most common pediatric cancer , , ... leukemia cells predicts which children with acute lymphoblastic leukemia ... online Jan. 7 in the New England Journal ... physicians fine-tune treatment for different subsets of patients. , ...
... SB 203, known as Emily,s Law, has received ... in the state of Ohio. Named after Emily Jerry, ... pharmacy technicians. The law, which was originally sponsored by ... National Pharmacy Technician Association. Emily,s Story , Emily ...
... used to treat heart failure, slowed cell growth, study ... a drug used for many years to treat irregular ... cancer-fighting agent, researchers report. , Cancer cells need to ... these cells are oxygen-deprived and need to switch on ...
... A medical revolution emerges when,technology blends with smart ... new Smart OR(TM) - a specialized neurosurgical suite ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081016/CLTH057 ... configuration of advanced imagery and mapping technology, the ...
Cached Medicine News:Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3Health News:Gene Governs Response to Leukemia Chemotherapy 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:Heart Drug May Be a Cancer Fighter 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3
... an in-vitro diagnostic test kit for ... cruzi in human serum/plasma. This test ... using gelatin particles coated with inactivated ... particles are agglutinated in the presence ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
Inquire...
Silicone ICD lead...
Medicine Products: